Sai Life Sciences Limited

₹1,744As of Sun 8 Nov 2026, 12:00 UTC
NSE:SAILIFEHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 15.18%
Diagnostics & Research
Beta (5Y) —
PE TTM 98.83
TSR TTM 89.94%
Mkt cap ₹370.5B
ROIC 12.84%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,912
9.63%
(45.96%)
Hold 9|5|7|1|1
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
21.05
20.94
20.86
20.08
18.40%
10.01%
4.50%
(4.98%)
Revenue₹B
22.50
23.25
23.76
23.59
1.39%
3.49%
2.51%
4.77%
Peers (US$3.999B)
Cap (US$)
PE
3.508B
56.47x
1.613B
74.47x
4.128B
32.58x
Capital
TTM
5Y
10Y
Leveragex
2.441
0.703
0.693
EBIT/Intx
0.766
0.153
0.109
Own earn%
15.63
(101.18)
(105.97)
Sh yield%
25.85
14.12
15.81
Owners
Insiders/Inst%
4.48
52.31
Short interest%
2.98
SBC / revenue%
0.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
11–15
$1 testx
—
Incr. ROIC%
4